<rst>
<header>
	<relations>
			<rel name="elaboration" type="rst"/>
			<rel name="means" type="rst"/>
			<rel name="background" type="rst"/>
			<rel name="circumstance" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="condition" type="rst"/>
			<rel name="purpose" type="rst"/>
			<rel name="restatement" type="rst"/>
			<rel name="evidence" type="rst"/>
			<rel name="evaluation" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">3. Discussion</segment>
<segment id="2" parent="1002" relname="span">The statistical analysis of the collected data at each visit shows a very good trend for hydrogel</segment>
<segment id="3" parent="1003" relname="span">containing trehalose and ceramides</segment>
<segment id="4" parent="3" relname="elaboration">based ingredient at each visit :</segment>
<segment id="5" parent="1005" relname="span">Evaporimetry</segment>
<segment id="6" parent="1006" relname="span">( Transepidermal Water Loss</segment>
<segment id="7" parent="6" relname="restatement">( TEWL ) )</segment>
<segment id="8" parent="1008" relname="span">Evaporimetry was used</segment>
<segment id="9" parent="1010" relname="span">to detect any influence on the water barrier function of the skin</segment>
<segment id="10" parent="9" relname="elaboration">following application of ceramides and trehalose</segment>
<segment id="11" parent="1010" relname="elaboration">based ingredient hydrogel and placebo hydrogel .</segment>
<segment id="12" parent="1012" relname="span">Corneometry</segment>
<segment id="13" parent="12" relname="elaboration">( Hydration )</segment>
<segment id="14" parent="15" relname="purpose">In order to measure the amount of water present in the stratum corneum and the skin barrier condition ,</segment>
<segment id="15" parent="1014" relname="span">hydration has been evaluated through Corneometry .</segment>
<segment id="16" parent="1018" relname="span">Moreover , the T-test applied to hydrogel</segment>
<segment id="17" parent="16" relname="elaboration">containing ceramides and trehalose based ingredient and placebo formula</segment>
<segment id="18" parent="1017" relname="same_unit">gave a statistically significant difference between them at each visit ,</segment>
<segment id="19" parent="1019" relname="span">always showing better results for the hydrogel</segment>
<segment id="20" parent="19" relname="elaboration">containing ceramides and trehalose based ingredient .</segment>
<segment id="21" parent="1021" relname="span">The double-blind , placebo-controlled study was performed</segment>
<segment id="22" parent="1022" relname="span">to assess , by corneometry and evaporimetry , the barrier normalizing efficacy of a topical product</segment>
<segment id="23" parent="1023" relname="span">containing trehalose and ceramides</segment>
<segment id="24" parent="23" relname="purpose">to alleviate skin dryness on limbs .</segment>
<segment id="25" parent="1025" relname="span">The study results show a significant moisturizing effect of the ingredient at each visit , both versus baseline and versus the placebo control</segment>
<segment id="26" parent="25" relname="elaboration">( p &lt; 0.01 ) .</segment>
<segment id="27" parent="1028" relname="span">For the application site of topical cosmetic formula</segment>
<segment id="28" parent="27" relname="elaboration">containing a trehalose and ceramides based ingredient :</segment>
<segment id="29" parent="1029" relname="joint">( 1 )</segment>
<segment id="30" parent="1030" relname="span">Transepidermal water loss</segment>
<segment id="31" parent="30" relname="elaboration">( TEWL )</segment>
<segment id="32" parent="1033" relname="span">value shows a reduction of −54 % after 4 weeks</segment>
<segment id="33" parent="32" relname="elaboration">(</segment>
<segment id="34" parent="1035" relname="preparation">Figure 2</segment>
<segment id="35" parent="1035" relname="span">) .</segment>
<segment id="36" parent="1037" relname="preparation">( 2 )</segment>
<segment id="37" parent="1037" relname="span">Hydration shows an increase of 102 % after 4 weeks</segment>
<segment id="38" parent="37" relname="elaboration">(</segment>
<segment id="39" parent="1040" relname="preparation">Figure 3</segment>
<segment id="40" parent="1040" relname="span">) .</segment>
<segment id="41" parent="1041" relname="span">Such results point out the significant moisturizing effect</segment>
<segment id="42" parent="1042" relname="joint">after using the cosmetic under examination</segment>
<segment id="43" parent="1043" relname="span">and go well with the rationale of the formulation ,</segment>
<segment id="44" parent="1044" relname="span">based on ingredients</segment>
<segment id="45" parent="1045" relname="joint">able to moisturize rapidly the skin</segment>
<segment id="46" parent="1046" relname="span">and recover the cutaneous barrier</segment>
<segment id="47" parent="46" relname="purpose">to allow it to better hold the water present into its outer layers .</segment>
<segment id="48" parent="1050" relname="span">In vivo evaluation of the efficacy of a formulation for atopic and very dry skin</segment>
<segment id="49" parent="48" relname="elaboration">( Xerosis )</segment>
<segment id="50" parent="1049" relname="same_unit">was done .</segment>
<segment id="51" parent="1053" relname="span">An example of one topical formulation for atopic dermatitis</segment>
<segment id="52" parent="51" relname="restatement">( Table 1 )</segment>
<segment id="53" parent="1054" relname="span">based on trehalose and ceramides</segment>
<segment id="54" parent="53" relname="elaboration">based ingredient</segment>
<segment id="55" parent="1051" relname="same_unit">is reported below for illustrative and non-limiting purposes .</segment>
<segment id="56" parent="1056" relname="span">Purpose of the test :</segment>
<segment id="57" parent="1058" relname="span">To provide active substances through a form</segment>
<segment id="58" parent="57" relname="elaboration">that allows a prompt release and an effective amount in atopic dermatitis ,</segment>
<segment id="59" parent="1060" relname="span">characterized by a deteriorated functionality of the barrier , an increased transepidermal water loss</segment>
<segment id="60" parent="59" relname="elaboration">( TEWL )</segment>
<segment id="61" parent="1061" relname="span">and a significant xerosis , as well as in the case of pathologies</segment>
<segment id="62" parent="61" relname="elaboration">associated with a local subcutaneous microcirculation disorder .</segment>
<segment id="63" parent="1063" relname="span">The efficacy of a topical cosmetic formulation</segment>
<segment id="64" parent="1064" relname="span">containing trehalose and ceramides in comparison to a placebo</segment>
<segment id="65" parent="64" relname="elaboration">has been evaluated .</segment>
<segment id="66" parent="1066" relname="span">Mean values , standard deviations , and variations were calculated for each set of values .</segment>
<segment id="67" parent="1068" relname="span">Following the results of normality test</segment>
<segment id="68" parent="67" relname="elaboration">( Kolmogorov – Smirnov test ) ,</segment>
<segment id="69" parent="1070" relname="span">the instrumental data</segment>
<segment id="70" parent="69" relname="elaboration">( T0 , T4 weeks )</segment>
<segment id="71" parent="1072" relname="span">and the variations</segment>
<segment id="72" parent="71" relname="elaboration">( T4 weeks-T0 )</segment>
<segment id="73" parent="1071" relname="same_unit">were statistically compared by means of t -test for parametric and dependent data .</segment>
<segment id="74" parent="1026" relname="joint">In all cases , the groups of data were considered statistically different for a probability value p &lt; 0.05 .</segment>
<segment id="75" parent="1076" relname="preparation">Protocol of double-blind study :</segment>
<segment id="76" parent="1076" relname="span">the product</segment>
<segment id="77" parent="1078" relname="span">containing trehalose and ceramides ingredient and the placebo was applied on the forearms by 20 volunteers of either sex</segment>
<segment id="78" parent="77" relname="elaboration">( 1 male and 19 females with an average age of 50 years )</segment>
<segment id="79" parent="1079" relname="span">with atopic and very dry skin</segment>
<segment id="80" parent="79" relname="elaboration">( xerosis ) , twice a day , for 4 weeks .</segment>
<segment id="81" parent="1081" relname="span">During the study , subjects were instructed to wash their body</segment>
<segment id="82" parent="1082" relname="joint">using their current skin care regimen</segment>
<segment id="83" parent="1082" relname="joint">and to not apply the tested products on any other site than the prescribed ones .</segment>
<segment id="84" parent="1026" relname="joint">For the whole duration of the test , the subjects were not allowed to use different products on the forearms</segment>
<segment id="85" parent="1026" relname="joint">and instructed to avoid UV exposure .</segment>
<segment id="86" parent="1089" relname="span">Furthermore , the side of application</segment>
<segment id="87" parent="86" relname="elaboration">( left or right forearm )</segment>
<segment id="88" parent="1088" relname="same_unit">of the two formulations</segment>
<segment id="89" parent="1090" relname="span">( cream</segment>
<segment id="90" parent="1091" relname="span">containing trehalose and ceramides</segment>
<segment id="91" parent="90" relname="elaboration">based ingredient and placebo )</segment>
<segment id="92" parent="1086" relname="same_unit">were randomized among the volunteers .</segment>
<segment id="93" parent="1095" relname="span">Each sample was labeled “ right ” or “ left ” ,</segment>
<segment id="94" parent="93" relname="elaboration">indicating the side of application of the product .</segment>
<segment id="95" parent="1096" relname="span">The assignment of subject number and subsequent placement on the randomization chart were made in order of appearance at the study center on the first day .</segment>
<segment id="96" parent="1097" relname="span">The products were given to the subjects in anonymous containers</segment>
<segment id="97" parent="96" relname="elaboration">which did not provide any information about the treatment .</segment>
<segment id="98" parent="1100" relname="span">The comparisons evidenced statistically significant differences between studied ingredient and placebo for both parameters</segment>
<segment id="99" parent="98" relname="elaboration">( hydration and TEWL ) .</segment>
<segment id="100" parent="1102" relname="attribution">This means</segment>
<segment id="101" parent="1102" relname="span">that the improvements</segment>
<segment id="102" parent="1103" relname="span">observed in the active area were statistically higher than the improvements</segment>
<segment id="103" parent="102" relname="elaboration">observed in the placebo area .</segment>
<segment id="104" parent="1107" relname="span">Instrumental measurements of skin hydration and transepidermal water loss</segment>
<segment id="105" parent="104" relname="elaboration">( TEWL )</segment>
<segment id="106" parent="1106" relname="same_unit">were performed on a selected area</segment>
<segment id="107" parent="1106" relname="restatement">( 9 cm2 )</segment>
<segment id="108" parent="1105" relname="elaboration">of the forearms at the baseline and after 4 weeks of treatment .</segment>
<segment id="109" parent="1109" relname="preparation">Skin Hydration</segment>
<segment id="110" parent="1110" relname="span">A statistically significant increase in the mean basal values of skin hydration was evidenced after 4 weeks of application of both the ceramides and trehalose based ingredient cream and the placebo product</segment>
<segment id="111" parent="110" relname="elaboration">( Table 2 ) .</segment>
<segment id="112" parent="1112" relname="span">A statistically significant difference between ceramides and trehalose</segment>
<segment id="113" parent="1113" relname="span">based ingredient cream and placebo product was detected after 4 weeks of treatment</segment>
<segment id="114" parent="113" relname="elaboration">(</segment>
<segment id="115" parent="1115" relname="preparation">Figure 4</segment>
<segment id="116" parent="1116" relname="preparation">) .</segment>
<segment id="117" parent="1117" relname="span">The cream</segment>
<segment id="118" parent="1118" relname="span">containing trehalose and ceramides</segment>
<segment id="119" parent="1119" relname="span">based ingredient is able to improve skin hydration</segment>
<segment id="120" parent="119" relname="condition">if compared to placebo .</segment>
<segment id="121" parent="1120" relname="span">Transepidermal Water Loss</segment>
<segment id="122" parent="121" relname="restatement">( TEWL )</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="span" parent="1004" relname="preparation"/>
<group id="1003" type="span" parent="2" relname="elaboration"/>
<group id="1004" type="multinuc" parent="1001" relname="span"/>
<group id="1005" type="span" parent="1004" relname="joint"/>
<group id="1006" type="span" parent="5" relname="elaboration"/>
<group id="1008" type="span" parent="1004" relname="joint"/>
<group id="1009" type="span" parent="8" relname="purpose"/>
<group id="1010" type="span" parent="1009" relname="span"/>
<group id="1012" type="span" parent="1004" relname="joint"/>
<group id="1014" type="span" parent="1004" relname="joint"/>
<group id="1016" type="multinuc" parent="1004" relname="joint"/>
<group id="1017" type="multinuc" parent="1016" relname="same_unit"/>
<group id="1018" type="span" parent="1017" relname="same_unit"/>
<group id="1019" type="span" parent="1016" relname="same_unit"/>
<group id="1021" type="span" parent="1004" relname="joint"/>
<group id="1022" type="span" parent="21" relname="purpose"/>
<group id="1023" type="span" parent="22" relname="elaboration"/>
<group id="1024" type="span" parent="1004" relname="joint"/>
<group id="1025" type="span" parent="1026" relname="preparation"/>
<group id="1026" type="multinuc" parent="1024" relname="span"/>
<group id="1027" type="span" parent="1026" relname="joint"/>
<group id="1028" type="span" parent="1027" relname="span"/>
<group id="1029" type="multinuc" parent="1028" relname="evidence"/>
<group id="1030" type="span" parent="1029" relname="joint"/>
<group id="1032" type="span" parent="1026" relname="joint"/>
<group id="1033" type="span" parent="1034" relname="preparation"/>
<group id="1034" type="span" parent="1032" relname="span"/>
<group id="1035" type="span" parent="1034" relname="span"/>
<group id="1036" type="span" parent="35" relname="evidence"/>
<group id="1037" type="span" parent="1036" relname="span"/>
<group id="1039" type="span" parent="1026" relname="joint"/>
<group id="1040" type="span" parent="1039" relname="span"/>
<group id="1041" type="span" parent="40" relname="elaboration"/>
<group id="1042" type="multinuc" parent="41" relname="circumstance"/>
<group id="1043" type="span" parent="1042" relname="joint"/>
<group id="1044" type="span" parent="43" relname="elaboration"/>
<group id="1045" type="multinuc" parent="44" relname="elaboration"/>
<group id="1046" type="span" parent="1045" relname="joint"/>
<group id="1049" type="multinuc" parent="1026" relname="joint"/>
<group id="1050" type="span" parent="1049" relname="same_unit"/>
<group id="1051" type="multinuc" parent="1026" relname="joint"/>
<group id="1052" type="multinuc" parent="1051" relname="same_unit"/>
<group id="1053" type="span" parent="1052" relname="same_unit"/>
<group id="1054" type="span" parent="1052" relname="same_unit"/>
<group id="1056" type="span" parent="1026" relname="joint"/>
<group id="1057" type="span" parent="56" relname="elaboration"/>
<group id="1058" type="span" parent="1057" relname="span"/>
<group id="1059" type="multinuc" parent="1058" relname="elaboration"/>
<group id="1060" type="span" parent="1059" relname="same_unit"/>
<group id="1061" type="span" parent="1059" relname="same_unit"/>
<group id="1063" type="span" parent="1026" relname="joint"/>
<group id="1064" type="span" parent="63" relname="elaboration"/>
<group id="1066" type="span" parent="1026" relname="joint"/>
<group id="1067" type="multinuc" parent="66" relname="elaboration"/>
<group id="1068" type="span" parent="1067" relname="same_unit"/>
<group id="1069" type="multinuc" parent="1067" relname="same_unit"/>
<group id="1070" type="span" parent="1069" relname="same_unit"/>
<group id="1071" type="multinuc" parent="1069" relname="same_unit"/>
<group id="1072" type="span" parent="1071" relname="same_unit"/>
<group id="1075" type="span" parent="1026" relname="joint"/>
<group id="1076" type="span" parent="1075" relname="span"/>
<group id="1077" type="multinuc" parent="76" relname="elaboration"/>
<group id="1078" type="span" parent="1077" relname="same_unit"/>
<group id="1079" type="span" parent="1077" relname="same_unit"/>
<group id="1081" type="span" parent="1026" relname="joint"/>
<group id="1082" type="multinuc" parent="81" relname="means"/>
<group id="1086" type="multinuc" parent="1026" relname="joint"/>
<group id="1087" type="span" parent="1086" relname="same_unit"/>
<group id="1088" type="multinuc" parent="1087" relname="span"/>
<group id="1089" type="span" parent="1088" relname="same_unit"/>
<group id="1090" type="span" parent="1088" relname="elaboration"/>
<group id="1091" type="span" parent="89" relname="elaboration"/>
<group id="1093" type="span" parent="1026" relname="joint"/>
<group id="1094" type="span" parent="1093" relname="span"/>
<group id="1095" type="span" parent="1096" relname="background"/>
<group id="1096" type="span" parent="1094" relname="span"/>
<group id="1097" type="span" parent="95" relname="elaboration"/>
<group id="1098" type="span" parent="1094" relname="elaboration"/>
<group id="1099" type="span" parent="1098" relname="span"/>
<group id="1100" type="span" parent="1099" relname="span"/>
<group id="1101" type="span" parent="1100" relname="evaluation"/>
<group id="1102" type="span" parent="1101" relname="span"/>
<group id="1103" type="span" parent="101" relname="elaboration"/>
<group id="1104" type="span" parent="1099" relname="elaboration"/>
<group id="1105" type="span" parent="1104" relname="span"/>
<group id="1106" type="multinuc" parent="1105" relname="span"/>
<group id="1107" type="span" parent="1106" relname="same_unit"/>
<group id="1108" type="span" parent="1026" relname="joint"/>
<group id="1109" type="multinuc" parent="1108" relname="span"/>
<group id="1110" type="span" parent="1109" relname="joint"/>
<group id="1112" type="span" parent="1109" relname="joint"/>
<group id="1113" type="span" parent="112" relname="elaboration"/>
<group id="1114" type="span" parent="1109" relname="joint"/>
<group id="1115" type="span" parent="1114" relname="span"/>
<group id="1116" type="multinuc" parent="1115" relname="span"/>
<group id="1117" type="span" parent="1116" relname="joint"/>
<group id="1118" type="span" parent="117" relname="elaboration"/>
<group id="1119" type="span" parent="118" relname="elaboration"/>
<group id="1120" type="span" parent="1116" relname="joint"/>
	</body>
</rst>
